“…MTX inhibits dihydrofolate reductase and is used widely for cancer chemotherapy (Frei et al, 1975;Jackson, 1984). Combined administration of MTX with other drugs, such as nonsteroidal anti-inflammatory drugs (NSAIDs) (Ellison and Servi, 1985;Maiche, 1986;Thyss et al, 1986;Ng et al, 1987;Tracy et al, 1992), penicillin antibiotics (Ronchera et al, 1993;Yamamoto et al, 1997;Titier et al, 2002), probenecid (Aherne et al, 1978), and ciprofloxacin (Dalle et al, 2002) can result in severe and life-threatening drug interactions. Of the drugs affecting the pharmacokinetics of MTX, NSAIDs have been well documented.…”